专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06211382B1 Process for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylaminocyclopentane intermediates 有权
标题翻译：制备1,3-二氮杂螺（4.4）非1-烯-4-酮衍生物和1-氰基-1-酰基氨基环戊烷中间体的方法
公开(公告)号：US06211382B1
公开(公告)日：2001-04-03
申请号：US09463357
申请日：2000-04-13
申请人： Csaba Huszár , Attila Kis-Tamás , Attila Németh , Zsuzsanna Nád , Zoltán Makovi , Antal Gajáry , Endre Kollár , Péter Aranyosi , Károly Gyüre , István Mészáros , Zsuzsanna Csetriné Hári , Attila Supic , Ilona Dervalicsne Zrinyi , Katalin Dubovszki , Lajosné Páli , Ágnes Kunsztné Kárász , Erzsébet Bognár
发明人： Csaba Huszár , Attila Kis-Tamás , Attila Németh , Zsuzsanna Nád , Zoltán Makovi , Antal Gajáry , Endre Kollár , Péter Aranyosi , Károly Gyüre , István Mészáros , Zsuzsanna Csetriné Hári , Attila Supic , Ilona Dervalicsne Zrinyi , Katalin Dubovszki , Lajosné Páli , Ágnes Kunsztné Kárász , Erzsébet Bognár
IPC分类号： C07D23502
CPC分类号： C07D235/02 , C07C255/46 , C07C2601/08
摘要： Process for the preparation of compounds of formula (I) wherein R means hydrogen atom, or C1-6 alkyl group, or C7-12 aralkyl group or phenyl group, characterised in that a) the compound of formula (III) is reacted with a compound of formula (IV) wherein X means halogen atom or C1-5 alkoxy group or hydroxyl group, and the resulting compound of formula (II) is transformed, in a reaction medium with pH above 7, into the compound of formula (I) or b) the compound of formula (III) is reacted with an anhydride of general formula (V) and the resulting compound of formula (II) transformed, in a reaction medium with pH above 7, into the compound of formula (I), or c) a compound of formula (II) is transformed, in a reaction medium with pH above 7, into the compound of formula (I), and if desired, the resulting compounds of formula (I), before or after isolation, are transformed into acid addition salts, or the compounds of formula (I) are liberated from their acid addition salts. Thus a process for the preparation of intermediates useful in synthesis of angiotensin II antagonists is disclosed.
摘要翻译：制备其中R表示氢原子或C 1-6烷基或C 7-12芳烷基或苯基的式（I）化合物的方法，其特征在于a）式（III）化合物与其中X表示卤素原子或C 1-5烷氧基或羟基的式（Ⅳ）化合物，将所得式（Ⅱ）化合物在pH高于7的反应介质中转化为式（I）化合物，或b）将式（III）化合物与通式（V）的酸酐反应，并将所得的式（II）化合物在pH高于7的反应介质中转化为式（I）化合物，或c）将式（II）化合物在pH高于7的反应介质中转化为式（I）化合物，如果需要，所得到的式（I）化合物在分离前或分离后为转化成酸加成盐，或式（I）化合物从其酸加成盐中释放出来。因此，公开了制备可用于合成血管紧张素II拮抗剂的中间体的方法。

2. 发明授权

US06624577B2 Tungsten-rhenium filament and method for producing same 有权
标题翻译：钨铼丝及其制造方法
公开(公告)号：US06624577B2
公开(公告)日：2003-09-23
申请号：US09812010
申请日：2001-03-19
申请人： István Mészáros , Tamás Gál , György Nagy , Béla Szeles
发明人： István Mészáros , Tamás Gál , György Nagy , Béla Szeles
IPC分类号： H01J1704
CPC分类号： H01K1/08
摘要： A tungsten-rhenium filament for an operation temperature between 2900 and 3200° K is disclosed. The filament comprises an aluminum-potassium-silicon (AKS) additive. The filament has a grain microstructure comprising substantially exclusively elongated interlocking grains with a Grain Aspect Ratio (GAR) not less than 12. The rhenium content of the filament is between 0.2-0.4% by weight. A method for manufacturing a rhenium-tungsten filament is also disclosed. The method comprises the following steps. An AKS doped tungsten-rhenium alloy powder is prepared with a rhenium content of 0.2-0.4% by weight. The alloy powder is pressed and presintered, and thereafter sintered with direct current. A rhenium-tungsten filament is formed, which has a metastable crystal structure. The filament is annealed below the recrystallisation temperature, and recrystallised above the crystallization temperature. There is also provided a halogen incandescent lamp with a glass envelope enclosing a tungsten-rhenium filament.
摘要翻译：公开了一种操作温度在2900和3200°K之间的钨 - 铼丝。长丝包括铝 - 钾 - 硅（AKS）添加剂。细丝具有包括基本上仅具有不小于12的晶粒长宽比（GAR）的细长互锁晶粒的晶粒微结构。细丝的铼含量在0.2-0.4重量％之间。还公开了一种制造铼钨丝的方法。该方法包括以下步骤。制备铼含量为0.2-0.4重量％的AKS掺杂钨 - 铼合金粉末。将合金粉末压制并预烧结，然后用直流电烧结。形成具有亚稳晶体结构的铼 - 钨丝。丝在低于再结晶温度下退火，并在结晶温度以上重结晶。还提供了一种卤素白炽灯，其中包围有钨 - 铼灯丝的玻璃信封。

3. 发明授权

US06597107B1 Tungsten-rhenium filament and method for producing same 有权
标题翻译：钨铼丝及其制造方法
公开(公告)号：US06597107B1
公开(公告)日：2003-07-22
申请号：US09683510
申请日：2002-01-11
申请人： István Mészáros , Tamás Gál , György Nagy , Zita Fábián
发明人： István Mészáros , Tamás Gál , György Nagy , Zita Fábián
IPC分类号： H01J162
CPC分类号： H01K1/08 , B22F5/12 , C22C1/045
摘要： A tungsten-rhenium filament is disclosed. The filament has a re-crystallization temperature above 2000° C., and it comprises an aluminum-potassium-silicon (AKS) additive. The potassium content of the filament is between 80-110 ppm, and the rhenium content is between 0.05-0.19% by weight. A method for manufacturing a rhenium-tungsten filament is also disclosed. The method comprises the following steps. An AKS doped tungsten-rhenium alloy powder is prepared with a rhenium content of 0.05-0.19% by weight, and a potassium content between 80-110 ppm. The alloy powder is pressed and presintered, and thereafter sintered with direct current. A rhenium-tungsten filament is formed which has a metastable crystal structure. The filament is wound on a mandrel, and it is annealed on the mandrel below the re-crystallization temperature. The filament is finally re-crystallized above the re-crystallization temperature. A halogen incandescent lamp with an envelope enclosing a tungsten-rhenium filament is also provided.
摘要翻译：公开了钨 - 铼丝。长丝具有高于2000℃的再结晶温度，并且其包含铝 - 钾 - 硅（AKS）添加剂。长丝的钾含量在80-110ppm之间，铼含量在0.05-0.19重量％之间。还公开了一种制造铼钨丝的方法。该方法包括以下步骤。制备AKS掺杂的钨 - 铼合金粉末，铼含量为0.05-0.19重量％，钾含量在80-110ppm之间。将合金粉末压制并预烧结，然后用直流电烧结。形成具有亚稳晶体结构的铼 - 钨丝。将丝缠绕在心轴上，并且在心轴上在再结晶温度下退火。最终在再结晶温度之上重新结晶细丝。还提供了一种带有包围钨 - 铼丝的信封的卤素白炽灯。

4. 发明授权

US06239286B1 Process for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylamino-cyclopentane intermediates 有权
标题翻译：制备1,3-二氮杂螺（4.4）非1-烯-4-酮衍生物和1-氰基-1-酰基氨基 - 环戊烷中间体的方法
公开(公告)号：US06239286B1
公开(公告)日：2001-05-29
申请号：US09463434
申请日：2000-05-15
申请人： Attila Kis-Tamás , Csaba Huszár , Bertrand Castro , Attila Németh , Péter Aranyosi , Károly Gyüre , István Mészáros , Ilona Dervalicsné Zrínyi , Katalin Dubovszki , Lajosné Páli , Antal Gajáry , Attila Supic , Zsuzsanna Nád , Zoltán Makovi , Endre Kollár , Zsuzsanna Csetriné Hári , Ágnes Kunsztné Kárász , Erzsébet Bognár
发明人： Attila Kis-Tamás , Csaba Huszár , Bertrand Castro , Attila Németh , Péter Aranyosi , Károly Gyüre , István Mészáros , Ilona Dervalicsné Zrínyi , Katalin Dubovszki , Lajosné Páli , Antal Gajáry , Attila Supic , Zsuzsanna Nád , Zoltán Makovi , Endre Kollár , Zsuzsanna Csetriné Hári , Ágnes Kunsztné Kárász , Erzsébet Bognár
IPC分类号： C07D23502
CPC分类号： C07D235/02 , C07C255/46 , C07C2601/08
摘要： Process for the preparation of compounds of formula (I) wherein R means hydrogen atom, or C1-6 alkyl group, or C7-12 aralkyl group or phenyl group, characterised in that: a) the compound of formula (III) is reacted with a compound of formula (IV) wherein X means halogen atom or C1-5 alkoxy group or hydroxyl group and the resulting compound of formula (II) is transformed in the presence of an oxidising agent in a reaction medium with pH above 7, into the compound of formula (I), or b) the compound of formula (III) is reacted with an anhydride of general formula (V) and the resulting compound of formula (II) transformed in the presence of an oxidising agent, in a reaction medium with pH above 7, into the compound of formula (I), or c) a compound of formula (II) is transformed in the presence of an oxidising agent, in a reaction medium with pH above 7, into the compound of formula (I), and if desired, the resulting compounds of formula (I), before or after isolation, are transformed into acid addition salts, or the compounds of formula (I) are liberated from their acid addition salts. Thus a process for the preparation of intermediates useful in synthesis of angiotensin II antagonists is disclosed.
摘要翻译：制备其中R表示氢原子或C 1-6烷基或C 7-12芳烷基或苯基的式（I）化合物的方法，其特征在于：a）将式（III）化合物与式（Ⅳ）化合物，其中X表示卤素原子或C 1-5烷氧基或羟基，所得式（II）化合物在氧化剂存在下，在pH高于7的反应介质中转化为式（I）化合物或b）使式（III）化合物与通式（V）的酸酐和所得的式（II）化合物在氧化剂存在下在反应介质中反应（II）的化合物转化成式（I）的化合物，或c）将式（II）化合物在氧化剂存在下，在pH高于7的反应介质中转化成式（I ），如果需要，所得到的式（I）化合物在分离之前或之后被转化为酸加成盐或式（I）化合物从其酸加成盐中释放出来。因此，公开了制备可用于合成血管紧张素II拮抗剂的中间体的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式